Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-03-08
2008-11-18
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07452860
ABSTRACT:
The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
REFERENCES:
patent: 3758683 (1973-09-01), Jackson
patent: 3868358 (1975-02-01), Jackson
patent: 4153689 (1979-05-01), Hirai et al.
patent: 4608364 (1986-08-01), Grau
patent: 4614730 (1986-09-01), Hansen et al.
patent: 4644057 (1987-02-01), Bicker et al.
patent: 4701440 (1987-10-01), Grau
patent: 4731405 (1988-03-01), Kirsch et al.
patent: 4783441 (1988-11-01), Thurow
patent: 4839341 (1989-06-01), Massey et al.
patent: 4885164 (1989-12-01), Thurow
patent: 4959351 (1990-09-01), Grau
patent: 4994439 (1991-02-01), Longenecker et al.
patent: 5008241 (1991-04-01), Markussen et al.
patent: 5034415 (1991-07-01), Rubin
patent: 5070186 (1991-12-01), Joergensen
patent: 5101013 (1992-03-01), Dorschug et al.
patent: 5177058 (1993-01-01), Dorschug
patent: 5358857 (1994-10-01), Stengelin et al.
patent: 5397771 (1995-03-01), Bechgaard et al.
patent: 5428006 (1995-06-01), Bechgaard et al.
patent: 5473049 (1995-12-01), Obermeier et al.
patent: 5474978 (1995-12-01), Bakaysa et al.
patent: 5496924 (1996-03-01), Habermann et al.
patent: 5506203 (1996-04-01), Backstrom et al.
patent: 5514646 (1996-05-01), Chance et al.
patent: 5534488 (1996-07-01), Hoffmann
patent: 5547929 (1996-08-01), Anderson, Jr. et al.
patent: 5559094 (1996-09-01), Brems et al.
patent: 5597796 (1997-01-01), Brange
patent: 5614219 (1997-03-01), Wunderlich et al.
patent: 5656722 (1997-08-01), Dorschug
patent: 5663291 (1997-09-01), Obermeier et al.
patent: 5693608 (1997-12-01), Bechgaard et al.
patent: 5700662 (1997-12-01), Chance et al.
patent: 5707641 (1998-01-01), Gertner et al.
patent: 5783556 (1998-07-01), Clark et al.
patent: 5824638 (1998-10-01), Burnside et al.
patent: 5932245 (1999-08-01), Wunderlich et al.
patent: 5948751 (1999-09-01), Kimer et al.
patent: 5985309 (1999-11-01), Edwards et al.
patent: 6034054 (2000-03-01), DeFelippis et al.
patent: 6043214 (2000-03-01), Jensen et al.
patent: 6051551 (2000-04-01), Hughes et al.
patent: 6100376 (2000-08-01), Dorschug
patent: 6174856 (2001-01-01), Langballe et al.
patent: 6211144 (2001-04-01), Havelund
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6267981 (2001-07-01), Okamoto et al.
patent: 6309663 (2001-10-01), Patel et al.
patent: 6310038 (2001-10-01), Havelund
patent: 6335316 (2002-01-01), Hughes et al.
patent: 6468959 (2002-10-01), Wunderlich et al.
patent: 6489292 (2002-12-01), Havelund et al.
patent: 6635617 (2003-10-01), Havelund
patent: 6734162 (2004-05-01), Van Antwerp et al.
patent: 6875589 (2005-04-01), Dorschug et al.
patent: 6908897 (2005-06-01), Brandenburg et al.
patent: 6960561 (2005-11-01), Boderke
patent: 7205276 (2007-04-01), Boderke
patent: 7205277 (2007-04-01), Boderke
patent: 2001/0031726 (2001-10-01), Van Antwerp et al.
patent: 2001/0033868 (2001-10-01), Rossling et al.
patent: 2001/0039260 (2001-11-01), Havelund
patent: 2002/0107265 (2002-08-01), Chen et al.
patent: 2002/0198140 (2002-12-01), Havelund
patent: 2003/0064097 (2003-04-01), Patel et al.
patent: 2004/0265268 (2004-12-01), Jain
patent: 2006/0074013 (2006-04-01), Van Antwerp et al.
patent: 2006/0210622 (2006-09-01), Pace et al.
patent: 2006/0287221 (2006-12-01), Knudsen et al.
patent: 62066/86 (1987-03-01), None
patent: 75916/87 (1988-01-01), None
patent: 4342485 (1995-12-01), None
patent: 1 258 427 (1989-08-01), None
patent: 2 219 635 (1972-11-01), None
patent: 32 40 177 (1983-05-01), None
patent: 0 018 609 (1980-11-01), None
patent: 0 046 979 (1982-03-01), None
patent: 0 132 769 (1985-02-01), None
patent: 0 132 770 (1985-02-01), None
patent: 0 133 283 (1985-02-01), None
patent: 0 166 529 (1986-01-01), None
patent: 0 180 920 (1986-05-01), None
patent: 0 194 864 (1986-09-01), None
patent: 0 200 383 (1986-12-01), None
patent: 0 200 383 (1986-12-01), None
patent: 0 211 299 (1987-02-01), None
patent: 0 214 826 (1987-03-01), None
patent: 0 224 885 (1987-06-01), None
patent: 0 227 938 (1987-07-01), None
patent: 0 254 516 (1988-01-01), None
patent: 0 305 760 (1989-03-01), None
patent: 0 368 187 (1990-05-01), None
patent: 0 375 437 (1990-06-01), None
patent: 0 383 472 (1990-08-01), None
patent: 0 419 504 (1991-04-01), None
patent: 0 600 372 (1994-06-01), None
patent: 0 668 292 (1995-08-01), None
patent: 0 678 522 (1995-10-01), None
patent: 0 837 072 (1998-04-01), None
patent: 1 172 114 (2002-01-01), None
patent: 2 456 522 (1980-12-01), None
patent: 1 527 605 (1978-10-01), None
patent: WO 83/00288 (1983-02-01), None
patent: WO 88/06599 (1988-09-01), None
patent: WO 89/10937 (1989-11-01), None
patent: WO 90/07522 (1990-07-01), None
patent: WO 91/16929 (1991-11-01), None
patent: WO 92/00321 (1992-01-01), None
patent: WO 94/14461 (1994-07-01), None
patent: WO 96/04307 (1996-02-01), None
patent: WO 96/07399 (1996-03-01), None
patent: WO 96/11705 (1996-04-01), None
patent: WO 96/41606 (1996-12-01), None
patent: WO 97/01331 (1997-01-01), None
patent: WO 98/42749 (1998-10-01), None
patent: WO 98/56406 (1998-12-01), None
patent: WO 99/24071 (1999-05-01), None
patent: WO 00/23098 (2000-04-01), None
patent: WO 00/23099 (2000-04-01), None
patent: WO 00/29013 (2000-05-01), None
patent: WO 00/74736 (2000-12-01), None
patent: WO 01/00223 (2001-01-01), None
patent: WO 01/12155 (2001-02-01), None
patent: WO 01/21154 (2001-03-01), None
patent: WO 01/28555 (2001-04-01), None
patent: WO 01/37808 (2001-05-01), None
patent: WO 01/43762 (2001-06-01), None
patent: WO 01/52937 (2001-07-01), None
patent: WO 01/93837 (2001-12-01), None
Co-pending U.S. Appl. No. 11/089,777, filed Mar. 25, 2005.
Kadima “Role of Metal Ions in the T- to R-Allosteric Transition in the Insulin Hexamer,” Biochem. 38(41), 1999, p. 13443.
Nettleton et al. “Characterization of the Oligomeric States of Insulin in Self-Assembly and Amyloid Fibril Formation by Mass Spectrometry,” Biophysical J., v79, 2000, p. 1053-1065.
Office Action dated Oct. 3, 2006 in co-pending U.S. Appl. No. 11/089,777, filed Mar. 25, 2005.
Office Action dated Apr. 25, 2007 in co-pending U.S. Appl. No. 11/089,777, filed Mar. 25, 2005.
Office Action dated Aug. 8, 2007 in co-pending U.S. Appl. No. 11/089,777, filed Mar. 25, 2005.
Office Action dated Dec. 19, 2007 in co-pending U.S. Appl. No. 11/089,777, filed Mar. 25, 2005.
Pillion et al., “Dodecylmaltoside-Mediated Nasal and Ocular Absorption of Lyspro-Insulin: Independence of Surfactant Action from Multimer Dissocation,” Pharm Res, vol. 15, No. 10, p. 1637 (1998).
Brange, et al., Toward Understanding Insulin Fibrillation,Journal of Pharmaceutical Sciences, 86:517-525 (1997).
Brange et al. “Chapter 13. Insulin Formulation and Delivery,” Protein Delivery, Physical Systems, 1997, p. 343-410.
Aoki, K, et al., Hydrolysis of Nonionic Surfactants,Ann. Rept. Takeda Res. Lab.27, 172-176 (1968).
Beintema, JJ, and RN Campagne, “Molecular Evolution of Rodent Insulins”,Mol. Biol. Evol.4(1):10-18, 1987.
Berger, Michael, “Towards more physiological insulin therapy in the 1990s—A comment,”Diabetes Research and Clinical Practice, 6 (1989), pp. S25-531.
Bolli, Geremia B., “The pharmacokinetic basis of insulin therapy in diabetes mellitus,”Diabetes Research and Clinical Practice, 6 (1989), pp. S3-S16.
Brange, “Galenics of Insulin,” 1987, p. 35-36.
Burgermeister et al., “D: The Isolation of Insulin from the Pancreas,” Insulin, Part 2, 1975, p. 715-727.
Dixon, Dr. G.H. et al., “Regeneration of Insulin Activity From the Separated and Inactive A and B Chains,”Nature, vol. 188, No. 4752 (1960), pp. 721-724.
Drury, P.L. et al., “Diabetic nephropathy,”British Medical Bull
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Russel Jeffrey E
Sanofi-Aventis Deutschland GmbH
LandOfFree
Zinc-free and low-zinc insulin preparations having improved... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc-free and low-zinc insulin preparations having improved..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc-free and low-zinc insulin preparations having improved... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4037322